Submitted:
19 October 2023
Posted:
20 October 2023
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Case Presentation
3. Discussion
4. Conclusions
5. Limitations
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
References
- Oliver, A.; Overton, C. Detecting ovarian disorders in primary care. Practitioner 2014, 258, 15–19. [Google Scholar]
- Pramana, C.; Almarjan, L.; Mahaputera, P.; Wicaksono, S.A.; Respati, G.; Wahyudi, F.; Hadi, C. A Giant Ovarian Cystadenoma in A 20-Year-Old Nulliparous Woman: A Case Report. Front Surg 2022, 9, 895025. [Google Scholar] [CrossRef]
- Kappen, T.; van Dulmen, S. General practitioners’ responses to the initial presentation of medically unexplained symptoms: a quantitative analysis. BioPsychoSocial Medicine 2008, 2, 22. [Google Scholar] [CrossRef]
- Albers, C.E.; Ranjit, E.; Sapra, A.; Bhandari, P.; Wasey, W. Clinician Beware, Giant Ovarian Cysts are Elusive and Rare. Cureus 2020, 12, e6753. [Google Scholar] [CrossRef]
- Foti, P.V.; Attinà, G.; Spadola, S.; Caltabiano, R.; Farina, R.; Palmucci, S.; Zarbo, G.; Zarbo, R.; D’Arrigo, M.; Milone, P.; et al. MR imaging of ovarian masses: classification and differential diagnosis. Insights Imaging 2016, 7, 21–41. [Google Scholar] [CrossRef]
- Diop, B.; Niang, M.M.; Ba, P.A.; Toure, P.S.; Sy, A.; Wane, Y.; Sarre, S.M. Management of Giant Ovarian Cysts: A Review of 5 Case Reports. Journal of Gynecologic Surgery 2016, 32, 162–166. [Google Scholar] [CrossRef]
- Peters, S.; Rogers, A.; Salmon, P.; Gask, L.; Dowrick, C.; Towey, M.; Clifford, R.; Morriss, R. What do patients choose to tell their doctors? Qualitative analysis of potential barriers to reattributing medically unexplained symptoms. J Gen Intern Med 2009, 24, 443–449. [Google Scholar] [CrossRef]
- Royal College of Obstetricians and Gynaecologists. Management of Suspected Ovarian Masses in Premenopausal Women. 2011, 14.
- Mobeen S., A. R. Ovarian Cyst; StatPearls Publishing: Treasure Island, FL, 2023. [Google Scholar]
- Terzic, M.; Aimagambetova, G.; Norton, M.; Della Corte, L.; Marín-Buck, A.; Lisón, J.F.; Amer-Cuenca, J.J.; Zito, G.; Garzon, S.; Caruso, S.; et al. Scoring systems for the evaluation of adnexal masses nature: current knowledge and clinical applications. J Obstet Gynaecol 2021, 41, 340–347. [Google Scholar] [CrossRef]
- Chai, A.L.; Huang, O.Y.; Rakočević, R.; Chung, P. Critical iron deficiency anemia with record low hemoglobin: a case report. J Med Case Rep 2021, 15, 472. [Google Scholar] [CrossRef]
- Mustafin, C.; Vesnin, S.; Turnbull, A.; Dixon, M.; Goltsov, A.; Goryanin, I. Diagnostics of Ovarian Tumors in Postmenopausal Patients. Diagnostics (Basel) 2022, 12. [Google Scholar] [CrossRef]
- Hall, G.H.; Turnbull, L.W.; Richmond, I.; Helboe, L.; Atkin, S.L. Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours. Br J Cancer 2002, 87, 86–90. [Google Scholar] [CrossRef]
- Fostira, F.; Papadimitriou, M.; Papadimitriou, C. Current practices on genetic testing in ovarian cancer. Ann Transl Med 2020, 8, 1703. [Google Scholar] [CrossRef]
- Gynecologists. , A.C.o.O.a. Practice Bulletin No. 174: Evaluation and Management of Adnexal Masses. 2016, 128, e210–e226. [CrossRef]
- Ross, E.K.; Kebria, M. Incidental ovarian cysts: When to reassure, when to reassess, when to refer. Cleve Clin J Med 2013, 80, 503–514. [Google Scholar] [CrossRef]
- Gynecology. , O. Practice Bulletin No. 174: Evaluation and Management of Adnexal Masses. Obstetrics & Gynecology 2016, 128, e210–e226. [Google Scholar] [CrossRef]
- Sutton, R.T.; Pincock, D.; Baumgart, D.C.; Sadowski, D.C.; Fedorak, R.N.; Kroeker, K.I. An overview of clinical decision support systems: benefits, risks, and strategies for success. npj Digital Medicine 2020, 3, 17. [Google Scholar] [CrossRef]
- Abu Sulb, A.; Abu El Haija, M.; Muthukumar, A. Incidental finding of a huge ovarian serous cystadenoma in an adolescent female with menorrhagia. SAGE Open Medical Case Reports 2016, 4, 2050313X16645755. [Google Scholar] [CrossRef]
- Protus, B.M. BMJ Best Practice. J Med Libr Association 2014, 102(3), 224–225. [Google Scholar] [CrossRef]
- Chawla, D.; Thukral, A.; Kumar, P.; Deorari, A. Harnessing mobile technology to deliver evidence-based maternal-infant care. Seminars in Fetal and Neonatal Medicine 2021. [Google Scholar] [CrossRef]
- Eide, H.; Quera, V.; Graugaard, P.; Finset, A. Physician–patient dialogue surrounding patients’ expression of concern: applying sequence analysis to RIAS. Social Science & Medicine 2004, 59, 145–155. [Google Scholar] [CrossRef]
- Levinson, W.; Gorawara-Bhat, R.; Lamb, J. A Study of Patient Clues and Physician Responses in Primary Care and Surgical Settings. Jama 2000, 284, 1021–1027. [Google Scholar] [CrossRef]
- Roter, D.L.; Hall, J.A.; Kern, D.E.; Barker, L.R.; Cole, K.A.; Roca, R.P. Improving physicians’ interviewing skills and reducing patients’ emotional distress: a randomized clinical trial. Archives of internal medicine 1995, 155, 1877–1884. [Google Scholar] [CrossRef]
- Axelrod, D.A.; Goold, S.D. Maintaining Trust in the Surgeon-Patient Relationship: Challenges for the New Millennium. Archives of Surgery 2000, 135, 55–61. [Google Scholar] [CrossRef]
- Detmar, S.; Aaronson, N.; Wever, L.; Muller, M.; Schornagel, J. How are you feeling? Who wants to know? Patients’ and oncologists’ preferences for discussing health-related quality-of-life issues. Journal of clinical oncology 2000, 18, 3295–3301. [Google Scholar] [CrossRef]
- Love, T.; Fahey, T. Defining diagnosis: screening and decision making in primary care. Br J Gen Pract 2003, 53, 914–915. [Google Scholar]
- Hall, J.A.; Irish, J.T.; Roter, D.L.; Ehrlich, C.M.; Miller, L.H. Satisfaction, gender, and communication in medical visits. Medical care 1994, 1216–1231. [Google Scholar] [CrossRef]
- Graugaard, P.K.; Holgersen, K.; Eide, H.; Finset, A. Changes in physician–patient communication from initial to return visits: a prospective study in a haematology outpatient clinic. Patient education and counseling 2005, 57, 22–29. [Google Scholar] [CrossRef]
- Huang, C.; Hong, M.K.; Ding, D.C. A review of ovary torsion. Ci Ji Yi Xue Za Zhi 2017, 29, 143–147. [Google Scholar] [CrossRef]
- Leite, C.; Barbosa, B.; Santos, N.; Oliveira, A.; Casimiro, C. Giant abdominal cyst in a young female patient: A case report. Int J Surg Case Rep 2020, 72, 549–555. [Google Scholar] [CrossRef]
- Lo, L.M.; Chang, S.D.; Horng, S.G.; Yang, T.Y.; Lee, C.L.; Liang, C.C. Laparoscopy versus laparotomy for surgical intervention of ovarian torsion. J Obstet Gynaecol Res 2008, 34, 1020–1025. [Google Scholar] [CrossRef]
- Ravishankar, T.N.; Makarand Jadhav, H.; Satheesh Kumar, N.; Ambala, S.; Pillai N, M. A deep learning approach for ovarian cysts detection and classification (OCD-FCNN) using fuzzy convolutional neural network. Measurement: Sensors 2023, 27, 100797. [Google Scholar] [CrossRef]
- Biggs, W.S.; Marks, S.T. Diagnosis and Management of Adnexal Masses. Am Fam Physician 2016, 93, 676–681. [Google Scholar]
- Andreotti, R.F.; Timmerman, D.; Strachowski, L.M.; Froyman, W.; Benacerraf, B.R.; Bennett, G.L.; Bourne, T.; Brown, D.L.; Coleman, B.G.; Frates, M.C.; et al. O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee. Radiology 2020, 294, 168–185. [Google Scholar] [CrossRef]
- Zhang, J.-J.; Cao, D.-Y.; Yang, J.-X.; Shen, K. Ovarian metastasis from nongynecologic primary sites: a retrospective analysis of 177 cases and 13-year experience. Journal of Ovarian Research 2020, 13, 128. [Google Scholar] [CrossRef]




| Category | Type |
|---|---|
| Benign | Physiological/Functional: Develops in response to overexaggerated physiological processes |
| Follicular | |
| Endometriotic | |
| Corpus luteum | |
| Theca lutein | |
| Infectious | |
| Abscess | |
| Cyst with infectious debris | |
| Benign Neoplastic: Overzealous growth of normal ovarian tissue | |
| Cystadenoma (e.g., mucinous) | |
| Adenofibroma | |
| Fibroma | |
| Dermoid Cyst (cystic teratoma) | |
| Brenner’s tumor | |
| Malignant | Primary Neoplastic: Dysplastic ovarian tissue |
| Immature teratoma | |
| Mucinous versus serous cystadenocarcinoma | |
| Endometroid carcinoma | |
| Germ cell tumors | |
| Metastatic: Dysplastic tissue not originating in the ovary | |
| Colonic, gastric, breast, endometrial, etc. [14] |
| Gynecological |
|---|
| Pregnancy, including miscarriage |
| Polycystic ovarian syndrome |
| Fibroids |
| Endometriosis |
| Endometritis, salpingitis |
| Hydrosalpinx |
| Ovarian cysts (different types) |
| Malignancy (primary or metastatic) |
| Pelvic inflammatory disease |
| Emergency: Torsion, rupture, hemorrhage, ectopic pregnancy |
| Nongynecological |
| Referred pain |
| Adhesions (from previous surgery) |
| Bowel obstruction |
| Psoas abscess |
| Appendicitis |
| Inflammatory bowel disease |
| Diverticulitis |
| Pelvic kidney |
| Urinary tract infection, pyelonephritis |
| Nephrolithiasis |
| Cancer (another primary site) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
